- The PE Playbook: 4 MedTech Companies, 4 Exits | Michael Bencak, 4x MedTech CEO
The PE Playbook: 4 MedTech Companies, 4 Exits | Michael Bencak, 4x MedTech CEO
- Breast Cancer Screening Without Radiation | Alexander Antrobus, Zedsen
Mammography has been the standard for breast cancer screening for decades, but is still struggles where the need is growing. Younger women with dense breast tissue are facing unreliable results, since fibroglandular tissue can mask a cancer entirely. Alexander Antrobus' device uses impedance sensing
- Building the Commercial Engine Behind a $1.75B Exit | Jose de la Cortina, Acandis
Building the Commercial Engine Behind a $1.75B Exit | Jose de la Cortina, Acandis
- Inside Catheter, Balloon and ePTFE Manufacturing | Robert Murray III, Aptyx
Inside Catheter, Balloon and ePTFE Manufacturing | Robert Murray III, Aptyx
- Insights From an Investor With 20+ MedTech Board Seats | Irit Yaniv, Almeda Ventures
What does a MedTech investor, board chair, and former CEO actually look for when evaluating a company? What makes them say no before the meeting is over? In this episode of the GS MedTech Podcast, we sat down with Dr. Irit Yaniv - a MedTech veteran who has sat on almost 20 boards and has held over 1
- Building a Deep Tech Company As a CEO, Not a Scientist | Maria Leiloglou, Enacuity
Dr. Maria Leiloglou spent years researching imaging technology for surgery before co-founding Enacuity - a software-only hyperspectral imaging solution that allows clinicians to see critical information about tissue oxygenation and blood perfusion with standard cameras. But building a company meant
- Automating Oxygen Therapy | Marie-Louise Little, O2matic
Oxygen therapy has been delivered the same way for over a century - manually, inconsistently, and wrong roughly 50% of the time for critical patients. In this episode, we sat down with Marie-Louise Little, CEO of O2matic, to explore why that's finally changing. Marie-Louise brings a rare dual perspe
- The Bone Adhesive Replacing Metal Hardware | Brian Hess, RevBio
Brian Hess, CEO of RevBio, joins our GS MedTech Podcast to discuss Tetranite - their bone adhesive biomaterial that bonds, load-bears, and regenerates bone simultaneously. Brian shares how RevBio secured over $20M in non-dilutive NIH grant funding, why they started with cranial flap fixation as thei
- What Great MedTech Leaders Do Differently | Ash Ross, The Change Work
What separates great MedTech leaders from the ones who struggle? We sat down with Ash Ross, an executive coach and former Medtronic leader, to explore the hidden dynamics that determine whether senior executives succeed or fail, in corporate giants and high-growth startups alike. Ash draws on decade
- Inside Next-Gen Orthopedic Implants | Maxwell Munford, OSSTEC
What does it take to build and scale a MedTech startup in orthopedics? In this episode of the GS MedTech Podcast, Max Munford, founder and CEO of OSSTEC, breaks down how next-generation orthopedic implants are being built and brought to market. We cover 3D printing, cementless surgery, product-marke
The GS MedTech
Podcast
Trends & Strategy
Most CEOs run the company they inherited. Michael runs the company the next buyer will pay for - and he’s done it successfully four times. In this episode of the GS MedTech Podcast, we sat down with Michael, who has spent nearly two decades leading PE-backed and family-owned businesses across MedTec
Mammography has been the standard for breast cancer screening for decades, but is still struggles where the need is growing. Younger women with dense breast tissue are facing unreliable results, since fibroglandular tissue can mask a cancer entirely.
Alexander Antrobus' device uses impedance sensing
In 2022, Baylis Medical was acquired by Boston Scientific for $1.75 billion. While to most, it was the technology that took the credit, Jose de la Cortina argues that the commercial engine is what closed the deal.
Jose spent 23 years at Baylis, joining when the company was six people and a Canadian d
The implant is what stays with the patient, so it gets all the attention. But as Robert puts it, an implant is just a pretty earring until someone builds a delivery system that can actually get it where it needs to go.
Robert is a Principal Engineer at Aptyx with a career spent on balloons, catheter
What does a MedTech investor, board chair, and former CEO actually look for when evaluating a company? What makes them say no before the meeting is over?
In this episode of the GS MedTech Podcast, we sat down with Dr. Irit Yaniv - a MedTech veteran who has sat on almost 20 boards and has held o
Dr. Maria Leiloglou spent years researching imaging technology for surgery before co-founding Enacuity - a software-only hyperspectral imaging solution that allows clinicians to see critical information about tissue oxygenation and blood perfusion with standard cameras.
But building a company meant m
Oxygen therapy has been delivered the same way for over a century - manually, inconsistently, and wrong roughly 50% of the time for critical patients. In this episode, we sat down with Marie-Louise Little, CEO of O2matic, to explore why that's finally changing.
Marie-Louise brings a rare dual perspec
Brian Hess, CEO of RevBio, joins our GS MedTech Podcast to discuss Tetranite - their bone adhesive biomaterial that bonds, load-bears, and regenerates bone simultaneously.
Brian shares how RevBio secured over $20M in non-dilutive NIH grant funding, why they started with cranial flap fixation as their
What separates great MedTech leaders from the ones who struggle? We sat down with Ash Ross, an executive coach and former Medtronic leader, to explore the hidden dynamics that determine whether senior executives succeed or fail, in corporate giants and high-growth startups alike.
Ash draws on decades
What does it take to build and scale a MedTech startup in orthopedics? In this episode of the GS MedTech Podcast, Max Munford, founder and CEO of OSSTEC, breaks down how next-generation orthopedic implants are being built and brought to market.
We cover 3D printing, cementless surgery, product-market